Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis Read more
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates Read more
Humanetics Corporation Receives Funding From Department of Defense to Test Drug Against COVID-19 Read more
Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa Read more
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine Read more
EU regulatory landscape and the impact of the FMD discussed at Parallel Trade Conference 2021 Read more
RNA Therapeutics Conference 2021 will explore industry insights into how mRNA is being used to combat COVID-19 Read more
Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U.S. research partners Read more